Artificial intelligence (AI) is revolutionizing biotechnology, enabling groundbreaking innovations across a wide range of applications. Recent developments, such as the $80 million funding round ...

A global AI in pharma and biotech industry valuation of US$ 1.8 billion was estimated for 2023. The market will reach US$ 13.1 billion by 2034, with a CAGR of 18.8% between 2024 and 2034. Healthcare ...

A survey conducted by ICON has found sentiment towards artificial intelligence (AI) and digital tools in the clinical research sector is positive, with 49% of pharmaceutical and biotechnology ...

With this rebranding, Binance intends to highlight its broader investment focus, which extends beyond blockchain technology to include artificial intelligence (AI) and biotechnology. gm we're ...

A group of biotechnology research companies based in Birmingham will receive $44 million in federal funding to research AI technology, federal officials announced this morning. The Birmingham ...